Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Deconinck

Showing results (181-190 of 236) with videos related to

Pageof 24
Sort By:
Haematologica|July 21, 2018
Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL groupLionel Adès, Xavier Thomas, Agnes Guerci Bresler, et al.
Haematologica|April 14, 2011
Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 studySteven Le Gouill, Sophie De Guibert, Lucie Planche, et al.
British Journal of Haematology|April 25, 2009
Extended diagnostic criteria for plasmacytoid dendritic cell leukaemiaFrancine Garnache-Ottou, Jean Feuillard, Christophe Ferrand, et al.
British Journal of Haematology|August 27, 2010
Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95Audrey Simon, Michel Peoch, Philippe Casassus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia GroupLionel Adès, Sylvie Chevret, Emmanuel Raffoux, et al.
European Journal of Haematology|January 17, 2013
Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie CellulaireSophie Park, Myriam Labopin, Ibrahim Yakoub-Agha, et al.
Bone Marrow Transplantation|June 19, 2025
Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AMLGuillaume Dachy, Myriam Labopin, Gérard Socié, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|January 10, 2018
A new approach for diagnosing chronic myelomonocytic leukemia using structural parameters of Sysmex XN<sup>TM</sup> analyzers in routine laboratory practiceFrançoise Schillinger, Elise Sourdeau, Marouane Boubaya, et al.
Blood Advances|January 4, 2018
Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1Jurjen Versluis, Myriam Labopin, Annalisa Ruggeri, et al.
European Journal of Haematology|September 20, 2014
Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto-SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM-TCPatrice Chevallier, Myriam Labopin, Gerard Socie, et al.
Pageof 24

Showing results (181-190 of 236) with videos related to

Sort By:
Pageof 24
Haematologica|July 21, 2018
Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL groupLionel Adès, Xavier Thomas, Agnes Guerci Bresler, et al.
Haematologica|April 14, 2011
Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 studySteven Le Gouill, Sophie De Guibert, Lucie Planche, et al.
British Journal of Haematology|April 25, 2009
Extended diagnostic criteria for plasmacytoid dendritic cell leukaemiaFrancine Garnache-Ottou, Jean Feuillard, Christophe Ferrand, et al.
British Journal of Haematology|August 27, 2010
Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95Audrey Simon, Michel Peoch, Philippe Casassus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia GroupLionel Adès, Sylvie Chevret, Emmanuel Raffoux, et al.
European Journal of Haematology|January 17, 2013
Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie CellulaireSophie Park, Myriam Labopin, Ibrahim Yakoub-Agha, et al.
Bone Marrow Transplantation|June 19, 2025
Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AMLGuillaume Dachy, Myriam Labopin, Gérard Socié, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|January 10, 2018
A new approach for diagnosing chronic myelomonocytic leukemia using structural parameters of Sysmex XN<sup>TM</sup> analyzers in routine laboratory practiceFrançoise Schillinger, Elise Sourdeau, Marouane Boubaya, et al.
Blood Advances|January 4, 2018
Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1Jurjen Versluis, Myriam Labopin, Annalisa Ruggeri, et al.
European Journal of Haematology|September 20, 2014
Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto-SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM-TCPatrice Chevallier, Myriam Labopin, Gerard Socie, et al.
Pageof 24